S&P 500

5.477,90

0,16%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
Hana Biosciences (HBX)
Hana Biosciences (HBX) Notícias

HBX

Hana Biosciences (HBX)

Hana Biosciences

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:AMEX:HBX

1

Data	Hora	Fonte	Título	Código	Companhia
11/04/2006	08:03	Business Wire	Hana Biosciences Obtains NASDAQ National Market Listing Approval; Hana Biosciences Shares to Trade Under Symbol HNAB on the NAS	AMEX:HBX	Hana Biosciences
05/04/2006	08:03	Business Wire	Hana Biosciences to Present at the BIO 2006 Business Forum	AMEX:HBX	Hana Biosciences
31/03/2006	12:03	Business Wire	Hana Biosciences to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceutical Conference	AMEX:HBX	Hana Biosciences
31/03/2006	09:03	Business Wire	Hana Biosciences Initiates Talotrexin Phase II Clinical Trials in Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)	AMEX:HBX	Hana Biosciences
22/03/2006	19:23	Business Wire	Hana Biosciences to Present at the Bear Stearns' Bear Biotech West Coast Confab	AMEX:HBX	Hana Biosciences
16/03/2006	06:03	Business Wire	Hana Biosciences Reports 2005 Results from Operations	AMEX:HBX	Hana Biosciences
09/03/2006	09:02	Business Wire	Hana Biosciences Successfully Completes Pivotal Trials of Zensana(TM), First Proprietary Ondansetron Oral Spray for Chemotherap	AMEX:HBX	Hana Biosciences
06/03/2006	10:30	Business Wire	Hana Biosciences to Present at the Lehman Brothers 9th Annual Global Healthcare Conference	AMEX:HBX	Hana Biosciences
02/03/2006	10:30	Business Wire	Hana Biosciences to Present at BioSquare 2006	AMEX:HBX	Hana Biosciences
28/02/2006	10:30	Business Wire	Hana Biosciences to Present at the Cowen & Co. 26th Annual Health Care Conference	AMEX:HBX	Hana Biosciences
14/02/2006	11:30	Business Wire	Hana Biosciences Announces Issuance of Talotrexin Patent	AMEX:HBX	Hana Biosciences
07/02/2006	11:27	Business Wire	Hana Biosciences to Present at the 8th Annual BIO CEO & Investor Conference	AMEX:HBX	Hana Biosciences
09/01/2006	11:14	Business Wire	Hana Biosciences Announces Positive Results of Initial Registration Trial with Zensana(TM), First Ondansetron Oral Spray for Che	AMEX:HBX	Hana Biosciences
05/01/2006	09:00	Business Wire	Hana Biosciences Announces 2006 Corporate Goals; Key 2005 Achievements Reviewed and 2006 Objectives Announced; Annual Shareholde	AMEX:HBX	Hana Biosciences
17/11/2005	15:07	Business Wire	Hana Biosciences Announces Positive In Vivo Preclinical Results Confirming Pharmacokinetics of Zensana(TM) (Ondansetron Oral Spr	AMEX:HBX	Hana Biosciences
14/11/2005	10:58	Business Wire	Hana Biosciences Announces Positive Interim Results From a Phase I Trial of Talotrexin (PT-523) in Relapsed or Refractory Non-Sm	AMEX:HBX	Hana Biosciences
07/11/2005	11:24	Business Wire	Hana Biosciences to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference	AMEX:HBX	Hana Biosciences
26/10/2005	10:28	Business Wire	Hana Biosciences to Present at 3rd Annual PIPES Conference	AMEX:HBX	Hana Biosciences
25/10/2005	10:30	Business Wire	Hana Biosciences Completes Previously Announced Private Placement	AMEX:HBX	Hana Biosciences
24/10/2005	09:58	Business Wire	Hana Biosciences to Present at Life Sciences Conference Hosted by C.E. Unterberg, Towbin	AMEX:HBX	Hana Biosciences
19/10/2005	17:41	Business Wire	Hana Biosciences Announces $14.7 Million Private Placement	AMEX:HBX	Hana Biosciences
03/10/2005	10:46	Business Wire	Hana Biosciences to Present at BioContact Quebec 2005	AMEX:HBX	Hana Biosciences
22/09/2005	14:45	PR Newswire (US)	American Stock Exchange Lists Common Stock of Hana Biosciences Incorporated	AMEX:HBX